Ambrx Biopharma, Inc.

CIK 1990550 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ambrx Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2024SC 13G/A0001172661-24-004740
Mar 18, 202415-12G0000950157-24-000430
Mar 12, 20248-K0000950157-24-000386
Mar 8, 2024S-8 POS0001193125-24-063394
Mar 8, 2024EFFECT9999999995-24-000625
Mar 8, 2024S-8 POS0001193125-24-063378
Mar 8, 2024S-8 POS0001193125-24-063372
Mar 8, 2024S-8 POS0001193125-24-063386
Mar 8, 2024S-8 POS0001193125-24-063370
Mar 7, 20248-K0001193125-24-061543
Mar 7, 202440000950170-24-028177
Mar 7, 202440000950170-24-028242
Mar 7, 202440000950170-24-028188
Mar 7, 202425-NSE/A0001354457-24-000131
Mar 7, 202440000950170-24-028171
Mar 7, 202440000950170-24-028190
Mar 7, 202440000950170-24-028250
Mar 7, 202440000950170-24-028182
Mar 7, 202440000950170-24-028186
Mar 7, 2024POS AM0001193125-24-061871
Mar 6, 20248-K0001193125-24-060712
Feb 23, 2024DEFA14A0001193125-24-044329
Feb 22, 2024DEFA14A0001193125-24-042135
Feb 22, 20248-K0001193125-24-042131
Feb 15, 2024DFAN14A0001193125-24-037665